Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.72 |
| ▸ | LMNA | P02545 | 3/20 | 0.72 |
| ▸ | HPGD | P15428 | 2/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.72 |
| ▸ | MAPT | P10636 | 1/20 | 0.72 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | TOP2A | P11388 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.65 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.65 |
| ▸ | PIK3CG | P48736 | 7/20 | 0.58 |
| ▸ | PIK3CD | O00329 | 5/20 | 0.58 |
| ▸ | PIK3R1 | P27986 | 5/20 | 0.58 |
| ▸ | PIK3CA | P42336 | 5/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2738824 | 0.90 | KDM4E (0.71) | KDM4EALDH1A1LMNAHPGDHSD17B10 | |
| SCHEMBL14113809 | 0.88 | KDM4E (0.75) | KDM4EALDH1A1LMNAHPGDHSD17B10 | |
| SCHEMBL13226802 | 0.87 | KDM4E (0.75) | KDM4EALDH1A1LMNAHPGDHSD17B10 | |
| SCHEMBL218256 | 0.86 | DRD3 (0.72) | KDM4EALDH1A1LMNAHPGDHSD17B10 | |
| SCHEMBL13464168 | 0.86 | KDM4E (0.74) | KDM4EALDH1A1LMNAHPGDHSD17B10 | |
| SCHEMBL2738822 | 0.86 | KDM4E (0.73) | KDM4EALDH1A1LMNAHPGDHSD17B10 | |
| SCHEMBL2738823 | 0.85 | KDM4E (0.70) | KDM4EALDH1A1LMNAHPGDHSD17B10 | |
| Enrofloxacin SCHEMBL28556438 | 0.84 | KDM4E (0.93) | KDM4EALDH1A1LMNAHPGDHSD17B10 | |
| SCHEMBL4629778 | 0.84 | KDM4E (0.77) | KDM4EALDH1A1LMNAHPGDHSD17B10 | |
| Enrofloxacin SCHEMBL149150 | 0.84 | KDM4E (1.00) | KDM4EALDH1A1LMNAHPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088918-B2 | Noncardiotoxic pharmaceutical compounds | WILLIAMSBURG HOLDINGS LLC (US) | 2012-01-03 | — | — | US | disclosed |
| CN-101432003-A | Non-cardiotoxic pharmaceutical compounds | BARBEAU DONALD L (US) | 2009-05-13 | — | — | CN | disclosed |
| US-5212291-A | Anthracycline derivatives as solubilized pro-drugs | AMERICAN CYANAMID COMPANY (US) | 1993-05-18 | — | — | US | disclosed |
| US-5116827-A | Antitumor agents | AMERICAN CYANAMID COMPANY (US) | 1992-05-26 | — | — | US | disclosed |
| US-5077283-A | Enhanced water and lipid solubility; antitumor, anticarcinogen ic agents | AMERICAN CYANAMID COMPANY (US) | 1991-12-31 | — | — | US | disclosed |
| US-5077282-A | Improved water or lipid solubility and reduced toxicity | AMERICAN CYANAMID COMPANY (US) | 1991-12-31 | — | — | US | disclosed |
| US-5070082-A | PHOSPHORYLATED DERIVATIVE OF PENTAMIDINE | AMERICAN CYANAMID COMPANY (US) | 1991-12-03 | — | — | US | disclosed |
| EP-0338372-A2 | Solubilized pro-drugs | AMERICAN CYANAMID COMPANY (US) | 1989-10-25 | — | — | EP | disclosed |